European science conversations
by the community, for the community
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
These articles have been produced as part of a data journalism initiative called 'Medicamentalia - Vaccines ' brought to you by the Civio Foundation. They outline some of the successes in vaccination campaigns from governments across the world. It also gives you a historical perspective on the key scientists who have been instrumental in developing vaccines of the past centuries. Find out more, it makes for an insightful reading. Read more [...]
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
This article has been produced as part of a data journalism initiative called 'Medicamentalia - Vaccines ' brought to you by the Civio Foundation. It outlines some of the successes in vaccination campaigns from governments across the world. It also gives you a historical perspective on the key scientists who have been instrumental in developing vaccines of the past centuries. Find out more, it makes for an insightful reading. Read more [...]
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
This article has been produced as part of a data journalism initiative called 'Medicamentalia - Vaccines ' brought to you by the Civio Foundation. It outlines some of the successes in vaccination campaigns from governments across the world. It also gives you a historical perspective on the key scientists who have been instrumental in developing vaccines of the past centuries. Find out more, it makes for an insightful reading. Read more [...]
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
The lack of vaccines is one of the biggest problems for immunisation in South Africa. The shortage of antigens is influenced by external problems, such as issues with pharmaceutical production and internal problems, such as poor management of stock, poor training, or staff shortages. It is a complex subject, in which the causes converge but there are many parties at fault. This is the fourth piece of a series from a data journalism initiative called 'Medicamentalia - Vaccines ' brought to you by the Civio Foundation. Read more [...]
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
This article has been produced as part of a data journalism initiative called 'Medicamentalia - Vaccines ' brought to you by the Civio Foundation. It outlines some of the successes in vaccination campaigns from governments across the world. It also gives you a historical perspective on the key scientists who have been instrumental in developing vaccines of the past centuries. Find out more, it makes for an insightful reading. Read more [...]
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
“Europe is sending us measles”, says Doctor Eduardo Suárez, director of the immunization programme at the Department of Health of El Salvador. And with good reason. Whilst the Americas declared itself to be free of this disease, outbreaks multiplied in significantly higher-income countries. Almost 26,000 cases were registered in Europe in 2015, far more than the 611 registered across the American continent, the majority of which were in Canada and the United States. Read more [...]
This article is sponsored by
Civio Foundation
Find out how to become a sponsor
The measles vaccine was invented in the 1960's, and by the 1980's its use was widespread. Decades later, however, the disease persists. Half of the countries in the world do not achieve immunisation rates sufficient to curb the transmission of illnesses such as measles. Similar scenarios apply to the polio and DTP vaccines. Find out more about the actual variying levels of vaccination uptake from around the world. In this piece of data journalism brought by the Civio Foundation, evidence shows that many avoidable diseases could reduce mortality, should countries implement suitable vaccination policies. There is still a long way to go to reduce avoidable death, preventable through vaccination. Read more [...]
In an attempt to dispel any fear of the unknown surrounding ebola, EuroScientist analyse the many facets of the current outbreak based on the opinion of a broad range of experts. Above all, we look at whether European countries are sufficiently prepared to make adequate policy decisions that will help end this outbreak and prevent future ones. Read more [...]
The Croatian Immunology Institute has entered administration and fired all of its workers – some 200 people, including research staff – despite being a profitable biotech firm with around 20 drugs and vaccines sold internationally. Read more [...]
EuroScientist journal 
